Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nathan R. Shelman"'
Autor:
Allison F. O’Neill, Alanna J. Church, Angela Feraco, Jennifer Spidle, Catherine B. Wall, Heung Bae Kim, Scott Elisofon, Khashayar Vakili, Max Pimkin, Neekesh V. Dharia, Nathan R. Shelman, Antonio R. Perez-Atayde, Carlos Rodriguez-Galindo
Publikováno v:
EBioMedicine, Vol 104, Iss , Pp 105147- (2024)
Summary: Background: Paediatric hepatocellular carcinomas (HCC) traditionally arise in the context of a normal structural and functional liver and carry a dismal prognosis. While chemotherapy is the frontline standard, there is emerging interest in t
Externí odkaz:
https://doaj.org/article/815517d7f0434bec859aea2d0054fc02
Autor:
Mikala M. Zelows, Corissa Cady, Nikitha Dharanipragada, Anna E. Mead, Zachary A. Kipp, Evelyn A. Bates, Venkateshwari Varadharajan, Rakhee Banerjee, Se-Hyung Park, Nathan R. Shelman, Harrison A. Clarke, Tara R. Hawkinson, Terrymar Medina, Ramon C. Sun, Todd A. Lydic, Terry D. Hinds, Jr., J. Mark Brown, Samir Softic, Gregory A. Graf, Robert N. Helsley
Publikováno v:
Molecular Metabolism, Vol 78, Iss , Pp 101815- (2023)
Background and aims: Genome and epigenome wide association studies identified variants in carnitine palmitoyltransferase 1a (CPT1a) that associate with lipid traits. The goal of this study was to determine the role of liver-specific CPT1a on hepatic
Externí odkaz:
https://doaj.org/article/2e4f326f6761408c9020ccde9aaab299
Publikováno v:
Cytopathology. 34:250-253
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 42
Background: Metabolic syndrome (MetS) is a cluster of risk factors that predisposes individuals to develop atherosclerotic cardiovascular disease, type 2 diabetes mellitus, and nonalcoholic fatty liver disease. Dyslipidemia is an essential element of
Autor:
Frederique Yiannikouris, Gertrude Arthur, Ryan E. Temel, Brett T. Spear, Gregory A. Graf, Nathan R. Shelman, Eva Gatineau, Kellea Nichols, Audrey Poupeau
Publikováno v:
Am J Physiol Endocrinol Metab
Obesity is associated with alterations in hepatic lipid metabolism. We previously identified the prorenin receptor (PRR) as a potential contributor to liver steatosis. Therefore, we aimed to determine the relative contribution of PRR and its soluble
Publikováno v:
American Journal of Gastroenterology. 116:S777-S777